Korean Journal of Radiology

  • 제13권5호
  • /
  • Pages.586-593
  • /
  • 2012
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Histologic Characteristics of Hepatocellular Carcinomas Showing Atypical Enhancement Patterns on 4-Phase MDCT Examination

  • Kim, Injoong (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine) ;
  • Kim, Myeong-Jin (Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine)
  • 발행 : 2012.10.01
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: To retrospectively define which histologic characteristics of small-sized hepatocellular carcinomas (HCCs) are related to atypical dynamic enhancement on multi-detector computed tomography (MDCT) imaging. Materials and Methods: Seventy-three patients with 83 HCCs (3 cm or less in diameter) were included in this study. All patients underwent 4-phase MDCT imaging and subsequent surgery within eight weeks. Two independent radiologists blinded to the histologic findings retrospectively classified the HCCs as either typical (showing increased enhancement on arterial phase images followed by washout in late phase images) or atypical lesions demonstrating any other enhancement pattern. From the original pathologic reports, various histologic characteristics including gross morphology, nuclear histologic grades, presence of capsule formation, and capsule infiltration when a capsule was present, were compared among the two groups. Results: An atypical enhancement pattern was seen in 30 (36.2%) of the 83 HCCs. The mean size of atypical HCCs (1.71 ${\pm}$ 0.764) was significantly smaller than that of typical HCCs (2.31 ${\pm}$ 0.598, p < 0.001). Atypical HCCs were frequently found to be vaguely nodular in gross morphology (n = 13, 43.3%) and to have grade I nuclear grades (n = 17, 56.7%). Capsule formation was significantly more common in typical HCCs (p < 0.001). Capsular infiltration was also more common in typical HCCs (p = 0.001). Conclusion: HCCs showing atypical dynamic enhancement on MDCT imaging are usually smaller than typical HCCs, vaguely nodular type in gross morphology in most cases, and well-differentiated in nuclear grades, and they lack of capsule formation or capsular infiltration.

키워드

참고문헌

  1. Choi BI, Lee JM. Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2010;17:369-373 https://doi.org/10.1007/s00534-009-0227-y
  2. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-1022 https://doi.org/10.1002/hep.24199
  3. Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 2006;101:513-523 https://doi.org/10.1111/j.1572-0241.2006.00467.x
  4. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008;247:311-330 https://doi.org/10.1148/radiol.2472061331
  5. Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 2005;11:281-289 https://doi.org/10.1002/lt.20357
  6. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156 https://doi.org/10.1002/ijc.1440
  7. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699 https://doi.org/10.1056/NEJM199603143341104
  8. Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005;42:27-34
  9. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990;336:1150-1153 https://doi.org/10.1016/0140-6736(90)92768-D
  10. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503 https://doi.org/10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
  11. Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008;47:97-104
  12. Hwang SH, Yu JS, Kim KW, Kim JH, Chung JJ. Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications. J Comput Assist Tomogr 2008;32:39-45 https://doi.org/10.1097/RCT.0b013e318064c76b
  13. Lee J, Lee WJ, Lim HK, Lim JH, Choi N, Park MH, et al. Early hepatocellular carcinoma: three-phase helical CT features of 16 patients. Korean J Radiol 2008;9:325-332 https://doi.org/10.3348/kjr.2008.9.4.325
  14. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N. Cirrhosis or chronic hepatitis: evaluation of small ( https://doi.org/10.1148/radiol.2262011967
  15. Hytiroglou P, Park YN, Krinsky G, Theise ND. Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am 2007;36:867-887, vii https://doi.org/10.1016/j.gtc.2007.08.010
  16. Monzawa S, Ichikawa T, Nakajima H, Kitanaka Y, Omata K, Araki T. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol 2007;188:147-153 https://doi.org/10.2214/AJR.05.0512
  17. Monzawa S, Omata K, Shimazu N, Yagawa A, Hosoda K, Araki T. Well-differentiated hepatocellular carcinoma: findings of US, CT, and MR imaging. Abdom Imaging 1999;24:392-397 https://doi.org/10.1007/s002619900521
  18. Nakashima Y, Nakashima O, Hsia CC, Kojiro M, Tabor E. Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver 1999;19:12-18 https://doi.org/10.1111/j.1478-3231.1999.tb00003.x
  19. Yoon SH, Lee JM, So YH, Hong SH, Kim SJ, Han JK, et al. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol 2009;193:W482-W489 https://doi.org/10.2214/AJR.08.1818
  20. Kim SH, Lee WJ, Lim HK, Park CK. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings. Korean J Radiol 2009;10:112- 120 https://doi.org/10.3348/kjr.2009.10.2.112
  21. International Consensus Group for Hepatocellular NeoplasiaThe International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009;49:658-664 https://doi.org/10.1002/hep.22709
  22. Ishizaki M, Ashida K, Higashi T, Nakatsukasa H, Kaneyoshi T, Fujiwara K, et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch 2001;438:574- 580 https://doi.org/10.1007/s004280000391
  23. Okuda K, Musha H, Nakajima Y, Kubo Y, Shimokawa Y, Nagasaki Y, et al. Clinicopathologic features of encapsulated hepatocellular carcinoma: a study of 26 cases. Cancer 1977;40:1240-1245 https://doi.org/10.1002/1097-0142(197709)40:3<1240::AID-CNCR2820400339>3.0.CO;2-Y
  24. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987;205:33-40 https://doi.org/10.1097/00000658-198701000-00006
  25. Lai EC, Ng IO, Ng MM, Lok AS, Tam PC, Fan ST, et al. Longterm results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology 1990;11:815-818 https://doi.org/10.1002/hep.1840110516
  26. Ng IO, Lai EC, Ng MM, Fan ST. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992;70:45-49 https://doi.org/10.1002/1097-0142(19920701)70:1<45::AID-CNCR2820700108>3.0.CO;2-7
  27. Takayasu K, Muramatsu Y, Mizuguchi Y, Okusaka T, Shimada K, Takayama T, et al. CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease. AJR Am J Roentgenol 2006;187:454-463 https://doi.org/10.2214/AJR.05.0705

피인용 문헌

  1. RE: Evaluation of Small Hepatocellular Carcinomas with Diffusion Weighted Imaging vol.14, pp.3, 2012, https://doi.org/10.3348/kjr.2013.14.3.544
  2. Liver metastasis from hepatoid adenocarcinoma of the stomach mimicking hepatocellular carcinoma: Dynamic computed tomography findings vol.21, pp.48, 2015, https://doi.org/10.3748/wjg.v21.i48.13524
  3. Preoperative Evaluation of the Histological Grade of Hepatocellular Carcinoma with Diffusion-Weighted Imaging: A Meta-Analysis vol.10, pp.2, 2012, https://doi.org/10.1371/journal.pone.0117661
  4. Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis vol.25, pp.11, 2015, https://doi.org/10.1007/s00330-015-3732-1
  5. Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre‐transplant population vol.59, pp.6, 2012, https://doi.org/10.1111/1754-9485.12347
  6. Lack of anti-tumor activity by anti-VEGF treatments in hepatic hemangiomas vol.19, pp.2, 2012, https://doi.org/10.1007/s10456-016-9494-9
  7. Spectral CT in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma : A retrospective study vol.96, pp.52, 2017, https://doi.org/10.1097/md.0000000000009236
  8. Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis vol.209, pp.3, 2012, https://doi.org/10.2214/ajr.16.17478